Tsha earnings
WebMar 31, 2024 · Net loss for the full year ended December 31, 2024, was $174.5 million or $4.64 per share, compared to a net loss of $60 million or $3.40 per share for the full year … Web8 hours ago · Charles Schwab ( SCHW) is due to post its Q1 earnings results before the bell on Monday. Shares of the Texas-based financial services giant have plummeted in the wake of Silicon Valley Bank’s ...
Tsha earnings
Did you know?
WebTSHA earnings history information, presented by NextEarningsDate.com. Period Earnings Date GAAP; Q3 2024: 11/8/2024-0.640: Q2 2024: 8/11/2024-0.840: Q1 2024 WebFounded. 2024. Taysha Gene Therapies, Inc.is a patient-centric, clinical-stage gene therapy company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include ...
WebMar 30, 2024 · Net loss for the full-year ended December 31, 2024 was $166 million or $3.78 per share, as compared to a net loss of $174.5 million, or $4.64 per share, for the full-year … WebDec 31, 2024 · Taysha Gene Therapies. (TSHA) is scheduled to report earnings on May 15, 2024.The last reported earnings were for reported on March 28, 2024 for Q4.
Web1 day ago · In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower ... WebNov 8, 2024 · Taysha Gene Therapies (TSHA) Recent Earnings. Taysha Gene Therapies (TSHA) reported a 3rd Quarter September 2024 loss of $0.64 per share on revenue of $0.0 …
WebMar 21, 2024 · With Taysha Gene Therapies stock trading at $0.71 per share, the total value of Taysha Gene Therapies stock (market capitalization) is $44.58M. Taysha Gene Therapies stock was originally listed at a price of $24.06 in Sep 24, 2024. If you had invested in Taysha Gene Therapies stock at $24.06, your return over the last 2 years would have been ...
WebGet Taysha Gene Therapies Inc (TSHA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. molly lahrWebView the latest Taysha Gene Therapies Inc. (TSHA) stock price, news, historical charts, analyst ratings and financial information from WSJ. hyundai line of suvWebMar 28, 2024 · This value represents a 68.94% increase compared to the same quarter last year. Zacks Investment Research reports that the 2024 Price to Earnings ratio for TSHA is … molly laidlawWebApr 11, 2024 · TSLA's full-year Zacks Consensus Estimates are calling for earnings of $3.84 per share and revenue of $101.83 billion. These results would represent year-over-year changes of -5.65% and +25% ... hyundai lithia springsWebYou can buy and sell Taysha Gene Therapies (TSHA) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. … hyundai line of vehiclesWebMar 19, 2024 · TSHA earnings call for the period ending December 31, 2024. Image source: The Motley Fool. Taysha Gene Therapies Inc. Common Stock (TSHA 5.54%) Q4 2024 … hyundai lithia renoWebMar 30, 2024 · Operator: Greetings, and welcome to the Taysha Gene Therapies Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only … hyundai lincolnwood il